Suven Life Sciences Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 2, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	32,311	24,730	21,742	10,570	13,484	8,961
Market Cap Growth	10.41%	13.74%	105.69%	-21.61%	50.48%	228.97%
Enterprise Value	29,736	23,067	19,870	10,468	13,313	8,934
Last Close Price	139.29	113.67	100.00	48.50	85.42	65.10
PS Ratio	457.56	371.55	185.94	77.75	112.83	63.67
PB Ratio	11.49	22.48	8.05	2.82	14.03	8.30
P/TBV Ratio	11.50	22.52	8.06	2.82	14.06	8.31
EV/Sales Ratio	-	346.57	169.93	77.00	111.40	63.48
Debt / Equity Ratio	-	-	0.00	0.00	0.03	0.04
Asset Turnover	-	0.03	0.04	0.06	0.10	0.09
Inventory Turnover	-	1.59	2.30	27.66	9.10	0.26
Quick Ratio	-	2.62	18.01	21.03	7.13	3.42
Current Ratio	-	3.21	18.99	22.61	8.01	6.45
Return on Equity (ROE)	-	-84.60%	-32.56%	-50.17%	-119.51%	-57.41%
Return on Assets (ROA)	-	-50.94%	-24.91%	-33.21%	-66.72%	-33.54%
Return on Invested Capital (ROIC)	-1188.91%	-423.40%	-149.73%	-133.77%	-218.87%	-82.85%
Return on Capital Employed (ROCE)	-	-153.30%	-49.50%	-35.00%	-126.60%	-74.00%
Earnings Yield	-8.50%	-6.50%	-4.83%	-11.19%	-9.05%	-8.05%
FCF Yield	-	-7.74%	-5.31%	-11.25%	-10.93%	-11.42%
Dividend Yield	-	-	-	-	1.17%	-
Buyback Yield / Dilution	-2.12%	-	-22.31%	-32.29%	-5.88%	-
Total Shareholder Return	-2.12%	-	-22.31%	-32.29%	-4.71%	-

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.